EHS
EHS

Humoral and cellular response to COVID-19 vaccines in patients with IBD




A new study published in the preprint server medRxiv* aimed to evaluate the humoral and cellular response to COVID-19 vaccine in patients with IBD undergoing biologic or immunomodulatory therapy.

Source link

EHS
Back to top button